Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
Management due diligence: getting under the bonnet
Almost half of PE investors believe external assessments are the most important method for evaluating a management team
Velocity, Holtzbrinck invest $12.5m in Bux
Total funding raised for the Dutch developer of a stock trading application is $35m so far
Triton backs Royal Reesink SBO
Equipment distributor Reesink was marketed based on €55-60m EBITDA, according to reports
Talkin' 'bout my generation: millennials in private equity
With millennials now making up the bulk of new entrants in PE, are GPs set up to match the new expectations of these young professionals?
Latest News
Farview Equity launches, inks first deal
New firm will target lower-mid-market enterprise and financial technology businesses in Europe
Eurazeo, BPI France et al. invest €70m in PayFit
Previous round for France-based fintech startup PayFit was a €14m series-B in 2017
ECM acquires Piketec
ECM will use equity from its German Equity Partners V fund, which closed on €325m in June 2018
Investindustrial buys Spanish stone surface producer Neolith
GP invests from its €2bn fund Investindustrial VI, which targets European mid-market companies